$ELTX
Elicio Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$1.85
▼-1.60%-$0.030
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateElicio Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ELTX down today? It is at $1.85 (-1.60%), and our scanner flagged it 28 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ELTX spikes, and full due diligence on ELTX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ELTX 28 times in the last 30 days. Create a free account to track $ELTX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ELTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ELTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Haqq Christopher Officer | Acquired (grant/award) | +25K 0.10% of company | added 79% | 57K | n/a | Feb 2, 26 |
Demuth Peter Officer | Acquired (grant/award) | +21K 0.08% of company | added 100% | 22K | n/a | Feb 2, 26 |
Shah Preetam Officer | Acquired (grant/award) | +24K 0.09% of company | n/a | 24K | n/a | Feb 2, 26 |
Connelly Robert Officer | Acquired (grant/award) | +74K 0.3% of company | added 100% | 121K | n/a | Feb 2, 26 |
Demuth Peter Officer | Other | 362 | added 95% | 743 | $2K at $4.41 | Dec 9, 25 |
Chudnovsky Yekaterina Director | Acquired (grant/award) | +3.50M 13.3% of company | added 100% | 5.42M | $20.3M at $5.81 | Mar 5, 25 |
Demuth Peter Officer | Other | 381 | n/a | 381 | $2K at $4.41 | Dec 16, 24 |
Venkatesan Jay Director | Other | 50K 0.2% of company | added 39% | 180K | $500 at $0.010 | Nov 26, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ELTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ELTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ELTX last traded at $1.85, down 1.60% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The ELTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ELTX 28 times in the last 30 days.
ELTX (Elicio Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $49M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ELTX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ELTX discussion
Sign in to ask a question or join the discussion.